Search Results for "tumor board" | Oncology Voice Network

Michael Pietrack

Leadership Lab: 10 Ways Executives Can Stay Visible, Valuable Between Jobs

Oct 22^nd • 5 mins read

Michael Pietrack

Managing Emotions After Being Downsized

Oct 21^st • 5 mins read

Michael Pietrack

The Great Resignation is Now The Great Hesitation

Nov 19^th • 5 mins read

Forbes Books Press Release Official

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Sep 9^th • 5 mins read

Tom Caravela

Job Search Checklist for Aspiring Medical Science Liaisons

May 17^th • 2 mins read

Tom Caravela

Resume Writing and Editing Tips for Pharma Professionals

Aug 8^th • 1 min read

Tom Caravela

MSL People Skills: Top 10 Tips for Better Engagement

Apr 20^th • 8 mins read

Tom Caravela

Promotability: How to Land Your Next Promotion

May 5^th • 10 mins read

Bridget Rasmusson

Positioning Yourself to Become an MSL in 2022

Dec 21^st • 10 mins read

Tom Caravela

What to do When a Job Offer is Rescinded

Jul 20^th • 5 mins read

iNIZIO

Transforming oncology: Five frontiers driving progress in cancer care

May 16^th • 5 mins read

iNIZIO

Expert perspectives live from ASCO® 2025

Jul 2^nd • 1 min read

A. Haslam, M.S. Kim, V. Prasad

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Apr 20^th • 7 mins read

Pai, Rekha

Advances in basic research in oncology in 2020: Bridging basic science and clinical care

Mar 24^th • 1 min read

Avi Cherla, MSc; Huseyin Naci, MHS, PhD; Aaron S. Kesselheim, MD, JD, MPH; Bishal Gyawali, MD, PhD; Elias Mossialos, MD, PhD

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

Feb 22^nd • 10 mins read

Paulo J. Oliveira, Ana M. Urbano

“Oncometabolism: The switchboard of cancer: An editorial”

Feb 1^st • 1 min read

Carrie Printz

First person profile: William Sellers, MD

Nov 6^th • 2 mins read

Siddharth Agrawal, Nidhi Bansal

Advances and Challenges in Pediatric and Childhood Cancers

Jun 27^th • 2 mins read

E.M. Ray, L.A. Carey, K.E. Reeder-Hayes

Leveraging existing data to contextualize phase II clinical trial findings in oncology

Sep 21^st • 3 mins read

Peter N Morcos, Junyi Li, Iraj Hosseini, Chi‐Chung Li

Quantitative Clinical Pharmacology of T‐Cell Engaging Bispecifics: Current Perspectives and Opportunities

Nov 18^th • 15 mins read

Navigation

Results for 'tumor board'

Leadership Lab: 10 Ways Executives Can Stay Visible, Valuable Between Jobs

Managing Emotions After Being Downsized

The Great Resignation is Now The Great Hesitation

New Book Unites Oncology’s Brightest Minds To Innovate Cancer Cures

Job Search Checklist for Aspiring Medical Science Liaisons

Resume Writing and Editing Tips for Pharma Professionals

MSL People Skills: Top 10 Tips for Better Engagement

Promotability: How to Land Your Next Promotion

Positioning Yourself to Become an MSL in 2022

What to do When a Job Offer is Rescinded

Transforming oncology: Five frontiers driving progress in cancer care

Expert perspectives live from ASCO® 2025

Updated estimates of eligibility for and response to genome-targeted oncology drugs among US cancer patients, 2006-2020

Advances in basic research in oncology in 2020: Bridging basic science and clinical care

Assessment of Coverage in England of Cancer Drugs Qualifying for US Food and Drug Administration Accelerated Approval

“Oncometabolism: The switchboard of cancer: An editorial”

First person profile: William Sellers, MD

Advances and Challenges in Pediatric and Childhood Cancers

Leveraging existing data to contextualize phase II clinical trial findings in oncology

Quantitative Clinical Pharmacology of T‐Cell Engaging Bispecifics: Current Perspectives and Opportunities

Related Topics